» Articles » PMID: 35530507

The Gut Microbiota in Liver Transplantation Recipients During the Perioperative Period

Overview
Journal Front Physiol
Date 2022 May 9
PMID 35530507
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic liver disease is a global problem, and an increasing number of patients receive a liver transplant yearly. The characteristics of intestinal microbial communities may be affected by changes in the pathophysiology of patients during the perioperative. We studied gut fecal microbial community signatures in 37 Chinese adults using 16S rRNA sequencing targeting V3-V4 hypervariable regions, with a total of 69 fecal samples. We analyzed the Alpha and Beta diversities of various groups. Then we compared the abundance of bacteria in groups at the phylum, family, and genus levels. The healthy gut microbiota predominantly consisted of the phyla Firmicutes and Bacteroidestes, followed by Proteobacteria and Actinobacteria. Compared with healthy people, due to the dominant bacteria in patients with chronic liver disease losing their advantages in the gut, the antagonistic effect on the inferior bacteria was reduced. The inferior bacteria multiplied in large numbers during this process. Some of these significant changes were observed in bacterial species belonging to , , and , which increased in patients' intestines. There were low abundances of signature genes such as , , and . and (considered probiotics) almost disappeared after liver transplantation. There is an altered microbial composition in liver transplantation patients and a distinct signature of microbiota associated with the perioperative period.

Citing Articles

Effect of gut microbiota changes on cytokines IL-10 and IL-17 levels in liver transplantation patients.

Abdel-Raoof Fouda M, Abdel-Wahhab M, Abdelkader A, Ibrahim M, Elsheikh T, Aldeweik H BMC Infect Dis. 2025; 25(1):140.

PMID: 39885417 PMC: 11780876. DOI: 10.1186/s12879-025-10466-9.


Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.

Medina C, Aykut B Biomedicines. 2025; 12(12.

PMID: 39767699 PMC: 11673786. DOI: 10.3390/biomedicines12122792.


Transplant-Acquired Food Allergy in Children.

Indolfi C, Klain A, Dinardo G, Grella C, Perrotta A, Colosimo S Nutrients. 2024; 16(18).

PMID: 39339801 PMC: 11434934. DOI: 10.3390/nu16183201.


Identification and comparison of intestinal microbial diversity in patients at different stages of hepatic cystic echinococcosis.

Akhlaghi E, Salari E, Mansouri M, Shafiei M, Kalantar-Neyestanaki D, Aghassi H Sci Rep. 2024; 14(1):18912.

PMID: 39143364 PMC: 11324937. DOI: 10.1038/s41598-024-70005-5.


The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations.

Assimakopoulos S, Bhagani S, Aggeletopoulou I, Tsounis E, Tsochatzis E Infection. 2024; 52(3):723-736.

PMID: 38324146 PMC: 11143052. DOI: 10.1007/s15010-024-02182-4.


References
1.
Yao C, Fung J, Chu N, Tan V . Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018; 52(8):663-673. DOI: 10.1097/MCG.0000000000001071. View

2.
Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L . Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr. 2010; 122 Suppl 2:26-30. DOI: 10.1007/s00508-010-1347-8. View

3.
Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A . Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015; 17(5):662-71. PMC: 4433427. DOI: 10.1016/j.chom.2015.03.005. View

4.
Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

5.
Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View